TNF Pharmaceuticals announced that it has changed its corporate name to Q/C Technologies and will begin trading under the new ticker symbol (QCLS) on Nasdaq, effective as of the market open on Thursday, September 25. Until then, the company’s common stock will continue to trade under its current ticker symbol (TNFA). The company also noted that it continues to evaluate strategic options for its legacy therapeutic programs, isomyosamine and Supera-CBD.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNFA:
- TNF Pharmaceuticals regains compliance with Nasdaq
- TNF Pharmaceuticals Secures $7M in Private Placement
- TNF Pharmaceuticals Enters Licensing Agreement with LightSolver
- PharmaCyte Biotech increases stake in TNF Pharmaceuticals by $3M
- TNF Pharmaceuticals gets rights to LightSolver tech for crypto applications